C. Elegans (oocyte)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef2c/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef2c/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef2b/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef2b/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef2a/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef2a/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef29/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef29/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef28/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef28/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef27/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef27/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef26/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef26/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef25/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef25/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef24/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef24/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef23/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef23/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef22/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef22/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef21/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef21/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef20/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef20/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef1f/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef1f/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef1e/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef1e/5cf6cba6b796ef04000eef0b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5cf6cc41b796ef04000eef1d/5cf6cba6b796ef04000eef0b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5cf6cc41b796ef04000eef1d/5cf6cba6b796ef04000eef0b.png"}]